Cerebrospinal Fluid Drainage Catheter Market Size, Share & Trends Analysis Report By Type (Lumbar Drainage Catheter, Ventricular Drainage Catheter), By Application, By Region, And Segment Forecasts, 2021 - 2028

Report Overview

The global cerebrospinal fluid drainage catheter market size was valued at USD 257.34 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.5% from 2021 to 2028. The demand for Cerebrospinal Fluid (CSF) drainage catheters is anticipated to upsurge owing to the rising incidence of neurological disorders and increasing road accidents, which result in traumatic brain and spinal injuries. In addition, rapid technological advancement and a growing inclination toward minimally invasive procedures are expected to drive the demand for CSF drainage catheters over the forecast period. The current outbreak of COVID-19 has negatively impacted the market for CSF drainage catheters. During this period, brain-related surgeries are often being postponed or even canceled to lower transmission of the disease.

Neurosurgical procedures dropped to 55% in highly affected countries such as the U.S., India, Brazil, Russia, France, the U.K., Italy, and Spain. As COVID-19 cases skyrocketed in the U.S., in March 2020, the American College of Surgeons (ACS) issued a recommendation to postpone or cancel elective procedures. In addition, the supply chain, manufacturing activities, delivery schedules, and sale of CSF catheters have been disrupted due to the nationwide lockdowns in the past few months. However, the market is expected to rebound and grow over the forecast period as the governments of many nations have started easing lockdown measures and have resumed some of the elective procedures. However, the outbreak has created opportunities for local manufacturers.

Increasing incidence of cranial and spinal injuries/trauma across the globe is a key driver of the market. Road accidents and violence are the most common causes of head trauma and cranial injuries besides falls, sports injuries, and gunshot wounds. This leads to hospitalization and permanent disability for thousands of individuals each year. Elevated intracranial pressure after head and spinal injuries are considered to have an unfavorable outcome with a mortality rate of approximately 20.0%. According to the CDC, 1.5 to 2 million adults and children suffer a traumatic brain injury each year. Hospitalization rates were the highest among older adults aged 65 years and older (81%). Additionally, according to the WHO, every year, between 250,000 and 500,000 people suffer a spinal cord injury globally. The majority of these injuries are due to preventable causes, such as road traffic crashes, falls, or violence. Therefore, CSF drainage catheters have become a cornerstone of care owing to the rise in the number of traumatic brain and spinal injuries across the world.

Moreover, mounting cases of neurological disorders such as hemorrhagic and ischemic strokes, intracranial tumors, hydrocephalus, brain infection, aneurysm, and meningitis are anticipated to drive the market. For instance, as per the WHO, cerebrovascular stroke is the second most common cause of mortality and the third most common cause of disability globally and approximately 60 - 80% of all strokes are ischemic. This happens mainly due to blocked blood vessel that limits the blood supply to the brain or when a weakened blood vessel bursts and bleeds into the surrounding brain. In the past few years, the incidence rate of strokes has increased more than double majorly in low- and middle-income countries. For instance, India has reported a very high incident rate of ischemic stroke, which is one of the leading causes of death. According to a recent study by the All India Institutes of Medical Sciences 2016, around 1.8 million Indians suffer from stroke every year. This is expected to drive the market over the forecast period.

The U.S. dominated the North American market with a revenue share of over 80.0% in 2020 owing to the high incidence rate of cerebrovascular disorders, the availability of skilled neuro professionals, and advanced healthcare infrastructure. In addition, the rising number of neurovascular surgeries due to traumatic brain injuries will influence the regional industry growth. Moreover, an increase in the FDA approvals for CSF drainage catheters in clinical applications, such as head injury, spinal injury, subarachnoid hemorrhages, hydrocephalus, and inflammatory diseases of the cerebrospinal space, is responsible for facilitating the market growth in the region. Thus, the increasing prevalence of medical conditions is increasing the use of CSF drainage catheters, thereby boosting the market growth in the U.S.

Additionally, the growing inclination toward minimally or noninvasive neurosurgeries is projected to accelerate the growth of the market. This growing demand is due to the minimal pain associated with the procedure, safety, efficacy, cost efficiency, and rapid recovery as compared to traditional open surgeries. Moreover, minimally invasive neurovascular procedures involve fewer disruptions of adjacent tissues, making the procedure simpler and more natural. Furthermore, rising concern over aesthetics and natural appearance and less amount of blood loss during surgeries are expected to increase the demand for minimally invasive neurovascular procedures. These benefits are cumulatively responsible to help lower trauma and result in better patient outcomes, thereby expected to drive the market over the forecast period.

Type Insights

In 2020, the ventricular drainage catheter segment dominated the market with a share of over 70.0% and is expected to expand at the highest CAGR from 2021 to 2028. The high incidence rate of intraventricular hemorrhage and traumatic brain injuries, which may lead to intracranial bleeding (hemorrhage), is increasing the use of ventricular drain catheters to remove excess cerebrospinal fluid from the brain. According to the CDC, cerebral hemorrhage is the second leading cause of stroke in the U.S. and accounts for about 13% of all strokes. Similarly, as per the World Stroke Organization (WSO) fact sheet, there are over 13.7 million new strokes reported each year globally. Out of which, 60% of new hemorrhagic strokes occur in people under 70 years and 10% occur in people under 44 years. This is expected to drive the segment over the forecast period.

Moreover, the rising number of road accidents, which lead to traumatic brain injuries, advancements in medical technology, and increasing demand for minimally invasive procedures are few other factors expected to drive the ventricular drainage catheter segment over the forecast period. The number of trauma injuries is increasing worldwide, especially in developing countries such as India and China. As per the WHO, India accounts for the highest number of demises due to road traffic accidents. During the traumatic brain injury, a ventricular drainage catheter helps to drain excess cerebrospinal fluid that fills and surrounds ventricles of the brain and spinal cord to relieve pressure. This is likely to accelerate the growth of this segment over the forecast period.

Application Insights

The traumatic brain injury segment dominated the market with a share of over 40.0% in 2020 and is expected to exhibit the highest CAGR from 2021 to 2028. The high prevalence rate of TBIs owing to road mishaps, the act of violence, or fall is expected to propel the growth of the segment during the forecast period. This leads to hospitalization and lasting disability for thousands of individuals every year globally. For instance, as per the Brain and Spine Institute, every year in France, approximately 170,000 people suffer from traumatic brain injuries, which include mild and severe injuries. More than 10,000 people become permanently disabled post brain injuries. Similarly, as per the WHO report, a road-traffic mortality rate of 26.6 deaths per 100,000 population has been registered in Africa. This is projected to support the segment growth over the forecast period.

Moreover, as more people are involving in sport and recreational activities, the risk of traumatic brain and spinal injuries is increasing globally. For instance, as per Stanford Children’s Health, over 3.5 million injuries are reported annually among children. Similarly, according to the Canadian Institute of Health from 2016 to 2017, around 17,655 people were hospitalized due to sport-related injuries. Furthermore, traumatic brain injuries are a significant cause of disability in military settings. Gunshots or explosive blast exposure is a common cause of TBIs in active-duty military personnel. This is anticipated to demand the use of drainage catheters in order to remove the excess cerebrospinal fluid. This is expected to drive the market over the forecast period.

Regional Insights

North America dominated the market with a share of over 35.0% in 2020. This is attributed to the high incidence and prevalence of traumatic brain and spinal injuries as well as neurovascular disorders, such as intraventricular hemorrhage and ischemic strokes. For instance, according to the 2020 SCI Data Sheet from the National SCI Statistical Center (NSCISC), every year, around 17,810 new spinal cord injuries are reported in the U.S., which accounts for approximately 54 cases per one million people. Vehicle crashes (38.6%) are currently the leading cause of spinal injury, followed by falls (32.2%), violence (14.0%), and sports/recreation activities (7.8%). Moreover, the presence of a well-developed healthcare sector and major medical device companies, such as Medtronic, Natus Medical, and Integra LifeSciences, are contributing to the market growth in the region. Thus, the high prevalence of neurovascular disorders and injuries and the growing awareness among individuals regarding illness and treatment are driving the market in this region.

Asia Pacific is expected to expand at the highest CAGR of 4.9% from 2021 to 2028. The presence of a large patient base in emerging economies, along with rising healthcare expenditure in this region, is expected to drive the market in this region. Additionally, high R&D investments by global market players in this region owing to their low-cost structure are projected to have a positive effect on the product demand over the forecast period. Furthermore, the growing geriatric population, along with the increasing incidence of brain injuries, is driving the market in this region. As per the WHO report 2018, fall-related injuries in the elderly is a major health and social concern in China, approximately 18-44% of the elderly persons are reported to fall each year in China. This is expected to present significant growth opportunities for the market in this region.

Key Companies & Market Share Insights

The competitors in the market are either adding more features to their existing products or launching new product lines to gain a larger share of the market. These market players are constantly incorporating the latest technologies in their products in order to lower the overall cost of care. For instance, in April 2018, Arkis BioSciences (part of Integra LifeSciences) launched Endexo polymer macromolecule for neurosurgical use with its new CerebroFlo EVD Catheter. It is intended to reduce the potential for catheter obstruction frequently associated with conventional EVD catheters. Launches of such technologically advanced products are anticipated to boost the companies’ profits over the forecast period.

Furthermore, companies are adopting various strategies, such as mergers & acquisitions, partnerships, and product launches to strengthen their foothold in the market and provide competitive diversity. In addition, several companies are involved in geographic expansion to cater to the untapped market for CSF drainage catheters. For instance, in July 2019, Integra LifeSciences completed the acquisition of Arkis Biosciences Inc. - a company that offers a portfolio of neurosurgical devices, including EVD catheters. This acquisition will strengthen Integra’s offerings in the neurocritical care segment and its leading position in advanced catheter technology. Additionally, in January 2018, Aesculap AG (a subsidiary of B. Braun AG) together with Christoph Miethke GmbH & Co. KG (developer and distributor of neurosurgical devices) entered into a joint venture to form B. Braun Miethke GmbH & Co. KG. This collaboration is likely to reinforce the company’s offering in the CSF management market segments. Some prominent players in the global Cerebrospinal Fluid (CSF) drainage catheter market include:

• Natus Medical, Inc.

• Desu Medica

• Spiegelberg GmbH & Co. KG

• Integra LifeSciences Corporation

• Medtronic

• Moller Medical GmbH

• Sophysa SA

Cerebrospinal Fluid  Drainage Catheter Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global cerebrospinal fluid drainage catheter market report on the basis of type, application, and region:

• Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Lumbar Drainage Catheter

  • Ventricular Drainage Catheter

• Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Traumatic Brain Injury

  • Traumatic Spinal Injury

  • Subarachnoid Hemorrhage

  • Intracerebral Hemorrhage

  • Others

• Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE